Imexpharm Corp (IMP)

Ho Chi Minh
Currency in VND
48,100.0
+200.0(+0.42%)
Closed
IMP Scorecard
Full Analysis
Trading at a high P/E ratio relative to near-term earnings growth
Earnings results expected in 10 days
Fair Value
Day's Range
47,650.048,900.0
52 wk Range
28,092.256,500.0
Key Statistics
Edit
Bid/Ask
48,000.00 / 48,100.00
Prev. Close
47,900
Open
48,500
Day's Range
47,650-48,900
52 wk Range
28,092.2-56,500
Volume
300K
Average Volume (3m)
198.67K
1-Year Change
70.13%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
IMP Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
41,318.2
Downside
-14.10%
Members' Sentiments
Bearish
Bullish
ProTips
Prominent player in the Pharmaceuticals industry

Imexpharm Corp Company Profile

Imexpharm Corporation manufactures, processes, trades, imports, and exports pharmaceutical products in Vietnam and internationally. The company’s products include oral and injectable antibiotic, digestion, central nervous system, cardiovascular, diabetes, ophthalmology, musculoskeletal system, respiratory system, analgesic-anti-inflammatory- antipyretics, anti-histamines, anti-allergy, anti-parasitic, and external drugs, as well as vitamins and minerals, and supplement. It is also involved in the import and export of medical equipment and supplies, chemicals, materials for medicine manufacturing and packaging, and chemicals used for sterilization or disinfection in humans. The company was founded in 1977 and is headquartered in Cao Lanh, Vietnam.

Employees
1452
Market
Vietnam

Compare IMP to Peers and Sector

Metrics to compare
IMP
Peers
Sector
Relationship
P/E Ratio
24.9x18.5x−0.7x
PEG Ratio
1.48−0.670.00
Price/Book
3.4x2.1x2.6x
Price / LTM Sales
3.4x1.6x3.1x
Upside (Analyst Target)
−14.1%15.1%50.4%
Fair Value Upside
Unlock11.0%8.4%Unlock

Analyst Ratings

2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 41,318.2
(-14.10% Downside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 1931.94
Dividend Yield
1.04%
Industry Median 2.72%
Annualised payout
500
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Nov 27, 2024
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

FAQ

What Is the Imexpharm Corp (IMP) Stock Price Today?

The Imexpharm Corp stock price today is 48,100.00.

What Stock Exchange Does Imexpharm Corp Trade On?

Imexpharm Corp is listed and trades on the Ho Chi Minh stock exchange.

What Is the Stock Symbol for Imexpharm Corp?

The stock symbol for Imexpharm Corp is "IMP."

Does Imexpharm Corp Pay Dividends? What’s The Current Dividend Yield?

The Imexpharm Corp dividend yield is 0.95%.

What Is the Imexpharm Corp Market Cap?

As of today, Imexpharm Corp market cap is 7.41T.

What is Imexpharm Corp Earnings Per Share?

The Imexpharm Corp EPS is 1,931.94.

What Is the Next Imexpharm Corp Earnings Date?

Imexpharm Corp will release its next earnings report on 25 Feb 2025.

From a Technical Analysis Perspective, Is IMP a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.